brands
As Her Oral Contraceptive Needs Change, Her Source Doesn't Have To
Making Informed Choices
A Choice For Nursing Mothers
Watson Choices In Oral Contraceptives
Contact Us
Oral Contraceptives Home
Search Go

U.S. Prescribing Information

This section of oralcontraceptives.com contains product prescribing information and is intended for US Healthcare Professionals.

(Norethindrone and Ethinyl Estradiol)
(norethindrone tablets)
(norethindrone and ethinyl estradiol tablets, USP)
(levonorgestrel and ethinyl estradiol tablets, USP)
(norgestrel and ethinyl estradiol tablets, USP)
(levonorgestrel and ethinyl estradiol tablets, USP)
(norethindrone acetate and ethinyl estradiol tablets, USP)
(norethindrone acetate and ethinyl estradiol tablets, USP)
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
(norgestimate and ethinyl estradiol tablets, USP)
(norethindrone and ethinyl estradiol tablets, USP)
(norethindrone and mestranol tablets, USP)
(Norethindrone and Ethinyl Estradiol Tablets)
(norethindrone and ethinyl estradiol tablets, USP)
(norethindrone/ethinyl estradiol, USP)
(Norethindrone)
(norethindrone tablets, USP)
(Norethindrone and Ethinyl Estradiol)
(Norethindrone and Mestranol)
(norgestrel and ethinyl estradiol tablets, USP)
(levonorgestrel and ethinyl estradiol tablets, USP)
(desogestrel and ethinyl estradiol tablets, USP)
(levonorgestrel and ethinyl estradiol tablets, USP)
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
(Norenthindrone and Ethinyl Estradiol)
(norgestimate and ethinyl estradiol tablets, USP)
(levonorgestrel and ethinyl estradiol tablets, USP - triphasic regimen)
(norethindrone and ethinyl estradiol tablets, USP)
(ethynodiol diacetate and ethinyl estradiol tablets, USP)
(ethynodiol diacetate and ethinyl estradiol tablets, USP)

SAFETY INFORMATION

Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.
*Brand names are the trademarks of the products' manufacturers and/or owners.
**Products illustrated may not appear at actual size and/or exact color.
Watson Pharmaceuticals, Inc.

Copyright © 2003 - 2010 Watson Pharma, Inc. All rights reserved.
Terms of Use
Legal/Copyright Disclaimer Privacy Policy
This site is intended for US residents only. Site Last Updated: 2010-08-10